Exploring GIPC2 as a key prognostic marker in colorectal cancer linked to enhanced immune response
GIPC2 may serve as a potential prognostic marker for CRC patients. Its expression is significantly correlated with the immune response in CRC.
Authors
- Bin Yu (ORCID: https://orcid.org/0000-0001-8795-4592)
- Shuai Li (ORCID: https://orcid.org/0000-0003-4898-6473)
- Yanan Wang (ORCID: https://orcid.org/0000-0002-8568-8777)
- Liting Zhang (ORCID: https://orcid.org/0000-0003-3007-1507)
- Jiaoyang Gu
- Qi Xing (ORCID: https://orcid.org/0000-0001-5926-3276)
- Xin Yu
Institutions
- Second Hospital of Shandong University (CN)
Publication Details
- Journal
- Immunobiology
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1016/j.imbio.2025.153090
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shandong University